檢索結果 - Forastiere, Arlene A.
- Showing 1 - 20 results of 29
- Go to Next Page
-
1
-
2
-
3
-
4
A phase II trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a tria... 由 Argiris, Athanassios, Ghebremichael, Musie, Burtness, Barbara, Axelrod, Rita S., Deconti, Ronald C., Forastiere, Arlene A.
出版 2011Text -
5
-
6
-
7
Validation of brief symptom indexes among patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A trial of the ECOG‐ACRIN Cancer Research Group (E1302... 由 Oswald, Laura B., Lee, Ju‐Whei, Argiris, Athanassios, Webster, Kimberly A., Forastiere, Arlene A., Cella, David
出版 2020Text -
8
-
9
-
10
-
11
Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial 由 Argiris, Athanassios, Ghebremichael, Musie, Gilbert, Jill, Lee, Ju-Whei, Sachidanandam, Kamakshi, Kolesar, Jill M., Burtness, Barbara, Forastiere, Arlene A.
出版 2013Text -
12
Eastern Cooperative Oncology Group (E1201) randomized phase II trial of neoadjuvant preoperative paclitaxel/cisplatin/radiotherapy (RT) or irinotecan/cisplatin/RT in esophageal ade... 由 Kleinberg, Lawrence R., Catalano, Paul, Forastiere, Arlene A., Keller, Steven M., Mitchel, Edith P., Anne, Pramila Rani, Benson, Al B.
出版 2015Text -
13
Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression i... 由 Gilbert, Jill, Lee, Ju Whei, Argiris, Athanassios, Haigentz, Missak, Feldman, Lawrence Eric, Jang, Minyoung, Arun, Pattatheyil, Van Waes, Carter, Forastiere, Arlene A.
出版 2012Text -
14
Phase II Study of Irinotecan Plus Panitumumab as Second‐Line Therapy for Patients with Advanced Esophageal Adenocarcinoma 由 Yoon, Harry, Karapetyan, Lilit, Choudhary, Anita, Kosozi, Ramla, Bali, Gurvinder Singh, Zaidi, Ali H., Atasoy, Ajlan, Forastiere, Arlene A., Gibson, Michael K.
出版 2018Text -
15
Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern Cooperative Oncology Group E2303 由 Psyrri, Amanda, Lee, Ju-Whei, Pectasides, Eirini, Vassilakopoulou, Maria, Kosmidis, Efstratios K., Burtness, Barbara A., Rimm, David L., Wanebo, Harold J., Forastiere, Arlene A.
出版 2014Text -
16
-
17
Recurrence after Neoadjuvant Chemoradiation and Surgery for Esophageal Cancer: Does the Pattern of Recurrence Differ for Complete Responders and Those with Partial or No response? 由 Meguid, Robert A., Hooker, Craig M., Taylor, Joshua T., Kleinberg, Laurence R., Cattaneo, Stephen M., Sussman, Marc S., Yang, Stephen C., Heitmiller, Richard F., Forastiere, Arlene A., Brock, Malcolm V.
出版 2009Text -
18
Secondary Chemoprevention of Barrett’s Esophagus With Celecoxib: Results of a Randomized Trial 由 Heath, Elisabeth I., Canto, Marcia Irene, Piantadosi, Steven, Montgomery, Elizabeth, Weinstein, Wilfred M., Herman, James G., Dannenberg, Andrew J., Yang, Vincent W., Shar, Albert O., Hawk, Ernest, Forastiere, Arlene A.
出版 2007Text -
19
Early Postoperative Paclitaxel Followed by Concurrent Paclitaxel and Cisplatin With Radiation Therapy for Patients With Resected High-Risk Head and Neck Squamous Cell Carcinoma: Re... 由 Rosenthal, David I., Harris, Jonathan, Forastiere, Arlene A., Weber, Randal S., Ridge, John A., Myers, Jeffrey N., Garden, Adam S., Kuettel, Michael R., Sidhu, Kulbir, Schultz, Christopher J., Trotti, Andy, Ang, K. Kian
出版 2009Text -
20
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer 由 Forastiere, Arlene A., Zhang, Qiang, Weber, Randal S., Maor, Moshe H., Goepfert, Helmuth, Pajak, Thomas F., Morrison, William, Glisson, Bonnie, Trotti, Andy, Ridge, John A., Thorstad, Wade, Wagner, Henry, Ensley, John F., Cooper, Jay S.
出版 2013Text